Format

Send to

Choose Destination
Vaccine. 2014 Apr 25;32(20):2261-4. doi: 10.1016/j.vaccine.2014.02.082. Epub 2014 Mar 12.

Impact of immunization with Protein F on pulmonary clearance of nontypeable Haemophilus influenzae.

Author information

1
Medical Microbiology, Department of Laboratory Medicine Malmö, Lund University, Malmö, Sweden.
2
Medical Microbiology, Department of Laboratory Medicine Malmö, Lund University, Malmö, Sweden. Electronic address: kristian.riesbeck@med.lu.se.

Abstract

Nontypeable Haemophilus influenzae (NTHi) is one of the main aetiologies of childhood bacterial infections as well as exacerbations in COPD patients. Currently, no licensed NTHi vaccine exists. In the present study, we evaluated the potential of the conserved and ubiquitous surface protein Haemophilus Protein F (PF) as a vaccine candidate. Our results show that incubation of NTHi with anti-PF antibodies significantly increased the opsonophygocytosis of human promyelocytic leukemia cell line-derived granulocytes, leading to efficient killing of the bacteria (P≤0.05). The presence of anti-PF IgG titers in healthy adults (n=60) was investigated, and we found that 26% of healthy blood donors carried antibodies with the main antigenic epitope being PF(23-48). Finally, mice immunized with PF(23-48) attained a significantly increased capacity to clear NTHi as compared to a control group immunized with a peptide derived from Moraxella catarrhalis β-lactamase (P≤0.05). Taken together, our results indicate that PF is a potential NTHi-vaccine candidate.

KEYWORDS:

ABC-transporter; Epitope mapping; Haemophilus influenzae; Immunization; Mouse; Opsonophagocytosis; Protein F; Pulmonary clearance

PMID:
24631068
DOI:
10.1016/j.vaccine.2014.02.082
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center